CD81 engineered with endocytotic signals mediates HCV cell entry: Implications for receptor usage by HCV in vivo

Virology

Volumn 308, Issue 2, 2003, Pages 250-269

  Tan, Yee Joo ^a   Lim, Siew Pheng ^a   Ng, Patrick ^b   Goh, Phuay Yee ^a   Lim, Seng Gee ^a,b   Tan, Y H ^a   Hong, Wanjin ^a  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

CD81; Chimeric receptors; Endocytosis; Hepatitis C virus (HCV); Internalization; Low density lipoprotein receptor; Transferrin receptor; Virus replication

Indexed keywords

ANTIBODY; CD18 ANTIGEN; LOW DENSITY LIPOPROTEIN RECEPTOR; MEMBRANE ANTIGEN; RECOMBINANT PROTEIN; TRANSFERRIN RECEPTOR; VIRUS PROTEIN; VIRUS RECEPTOR;

ARTICLE; CHIMERA; CONTROLLED STUDY; CYTOPLASM; ENDOCYTOSIS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INTERNALIZATION; LIVER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ENGINEERING; RECEPTOR BINDING; RNA VIRUS; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 0037431206     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(02)00136-8     Document Type: Article

References (74)

1. Agnello V. The aetiology of mixed cryoglobulinaemia associated with hepatitis C virus infection. Scand. J. Immunol. 42:1995;179-184.
2. Agnello V., Abel G., Elfahal G.B., Knight G.B., Zhang Q.X. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 96:1999;12766-12771.
3. Allander T., Forns X., Emerson S.U., Purcell R.H., Bukh J. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins. Virology. 277:2000;358-367.
4. Angulo A., Alcami A., Vinuela E. Virus-host interactions in African swine fever the attachment to cellular receptors . Arch. Virol. Suppl. 7:1993;169-183.
5. Bartenschlager R., Lohmann V. Replication of hepatitis C virus. J. Gen. Virol. 81:2000;1631-1648.
6. Bartenschlager R., Lohmann V. Novel cell culture systems for the hepatitis C virus. Antiviral Res. 52:2001;1-17.
7. Beisiegel U., Schneider W.J., Goldstein J.L., Anderson R.G., Brown M.S. Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia. J. Biol. Chem. 256:1981;11923-11931.
8. Brideau A.D., Enquist L.W., Tirabassi R.S. The role of virion membrane protein endocytosis in the herpesvirus life cycle. J. Clin. Virol. 17:2000;69-82.
9. Bukh J., Purcell R.H., Miller R.H. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc. Nat. Acad. Sci. USA. 89:1992;4942-4946.
10. Chan S.W., McOmish F., Holmes E.C., Dow B., Peutherer J.F., Follett E., Yap P.L., Simmonds P. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J. Gen. Virol. 73:1992;1131-1141.
11. Choo Q.-L., Richman K., Han J.H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby A., Barr P.J., Weiner A., Bradley D.W., Kuo G., Houghton M. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA. 88:1991;2451-2455.
12. Collawn J.F., Kuhn L.A., Liu L.-F.S., Tainer J.A., Trowbridge I.S. Transplanted LDL and mannose-6-phosphate receptor internalization signals promote high-efficiency endocytosis of the transferrin receptor. EMBO J. 10:1991;3247-3253.
13. Davis C.G., Goldstein J.L., Südhof T.C., Anderson R.G.W., Russell D.W., Brown M.S. Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region. Nature. 326:1987;760-765.
14. Deleersnyder V., Pillez A., Wychowski C., Blight K., Xu J., Hahn Y.S., Rice C.M., Dubuisson J. Formation of native hepatitis C virus glycoprotein complexes. J. Virol. 71:1997;697-704.
15. Dubuisson J. Folding, assembly and subcellular localization of hepatitis C virus glycoproteins. Curr. Top. Microbiol. Immunol. 242:2000;135-148.
16. Dubuisson J., Hsu H.H., Cheung R.C., Greenberg H.B., Russell D.G., Rice C.M. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J. Virol. 68:1994;6147-6160.
17. Favre D., Berthillon P., Trepo C. Removal of cell-bound lipoproteins: a crucial step for the efficient infection of liver cells with hepatitis C virus in vitro. C. R. Acad. Sci. III. 324:2001;1141-1148.
18. Flint M., Dubuisson J., Maidens C., Harrop R., Guile G.R., Borrow P., McKeating J.A. Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein. J. Virol. 74:2000;702-709.
19. Flint M., Maidens C., Loomis-Price L.D., Shotton C., Dubuisson J., Monk P., Higginbottom A., Levy S., McKeating J.A. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J. Virol. 73:1999;6235-6244.
20. Flint M., McKeating J.A. The role of the hepatitis C virus glycoproteins in infection. Rev. Med. Virol. 10:2000;101-117.
21. Flint M., Quinn E.R., Levy S. In search of hepatitis C virus receptor(s). Clin. Liver Dis. 5:2001;873-893.
22. Flint M., Thomas J.M., Maidens C.M., Shotton C., Levy S., Barclay W.S., McKeating J.A. Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. J. Virol. 73:1999;6782-6790.
23. Garson J.A., Ring C., Tuke P., Tedder R.S. Enhanced detection by PCR of hepatitis C virus RNA. Lancet. 336:1990;878-879.
24. Gaudin Y., Tuffereau C., Durrer P., Brunner J., Flamand A., Ruigrok R. Rabies virus-induced membrane fusion. Mol. Membr. Biol. 16:1999;21-31.
25. Goldstein J.L., Brown M.S., Anderson R.G.W., Russell D.W., Schneider W.J. Receptor-mediated endocytosis concepts emerging from the LDL receptor system . Annu. Rev. Cell Biol. 1:1985;1-39.
26. Grakoui A., Wychowski C., Lin C., Feinston S.M., Rice C.M. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67:1993;1385-1395.
27. Haigler H.T., Maxfield F.R., Willingham M.C., Pastan I. Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells. J. Biol. Chem. 255:1980;1239-1241.
28. Heile J.M., Fong Y.-L., Rosa D., Berger K., Saletti G., Campagnoli S., Bensi G., Capo S., Coates S., Crawford K., Dong C., Wininger M., Baker G., Cousens L., Chien D., Ng P., Archangel P., Grandi G., Houghton M., Abrignani S. Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates. J. Virol. 74:2000;6885-6892.
29. Herz J., Kowal R.C., Ho Y.K., Brown M.S., Goldstein J.L. Low density lipoprotein receptor-related protein mediates endocytosis of monoclonal antibodies in cultured cells and rabbit liver. J. Biol. Chem. 265:1990;21355-21362.
30. Higginbottom A., Quinn E.R., Kuo C.-C., Flint M., Wilson L.H., Bianchi E., Nicosia A., Monk P.N., McKeating J.A., Levy S. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J. Virol. 74:2000;3642-3649.
31. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Ohkoshi S., Shimotohno K. Hypervariable regions in the putative glycoprotein of Hepatitis C virus. Biochem. Biophys. Res. Commun. 175:1991;220-228.
32. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. USA. 88:1991;5547-5551.
33. Hijikata M., Shimizu Y.K., Kato H., Iwamoto A., Shih J.W., Alter H.J., Purcell R.H., Yoshikura H. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J. Virol. 67:1993;1953-1958.
34. Houghton M. Hepatitis C viruses. Fields B.N., Knipe D.M., Howley P.M. Fields Virology. 1996;1035-1058 Lippincott, Philadelphia, PA.
35. Hsu H.H., Donets M., Greenberg H.B., Feinstone S.M. Characterization of hepatitis C virus structural proteins with a recombinant baculovirus expression system. Hepatology. 17:1993;763-771.
36. Ishii K., Rosa D., Watanabe Y., Katayama T., Harada H., Wyatt C., Kiyosawa K., Aizaki H., Matsuura Y., Houghton M., Abrignani S., Miyamura T. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C. Hepatology. 28:1998;1117-1120.
37. Jones I.M., Chan-Fook C., Jiang W.-R., Clarke B.E. Receptors for hepatitis C virus. J. Virol. 74:2000;10860-10861.
38. Kanto T., Hayashi N., Takehara T., Hagiwara H., Mita E., Naito M., Kasahara A., Fusamoto H., Kamada T. Buoyant density of hepatitis C virus recovered from infected hosts: two different features in sucrose equilibrium density-gradient centrifugation related to degree of liver inflammation. Hepatology. 19:1994;296-302.
39. Kanto T., Hayashi N., Takehara T., Hagiwara H., Mita E., Naito M., Kasahara A., Fusamoto H., Kamada T. Density analysis of hepatitis C virus particle population in the circulation of infected hosts implications for virus neutralization or persistence . J. Hepatol. 22:1995;440-448.
40. Kielian M., Jungerwirth S. Mechanisms of enveloped virus entry into cells. Mol. Biol. Med. 7:1990;17-31.
41. Ktistakis N.T., Thomas D., Roth M.G. Characteristics of the tyrosine recognition signal for internalization of transmembrane surface glycoproteins. J. Cell Biol. 111:1990;1393-1407.
42. Lanford R.E., Sureau C., Jacob J.R., White R., Fuerst T.R. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology. 202:1994;606-614.
43. Levy S., Todd S.C., Maecker H.T. CD81 (TAPA-1) a molecule involved in signal transduction and cell adhesion in the immune system . Annu. Rev. Immunol. 16:1998;89-109.
44. Lim S.P., Khu Y.L., Hong W.J., Tay A., Ting A.E., Lim S.G., Tan Y.H. Identification and molecular characterisation of the complete genome of a Singapore isolate of hepatitis C virus sequence comparison with other strains and phylogenetic analysis . Virus Genes. 23:2001;89-95.
45. Maillard P., Krawczynski K., Nitkiewicz J., Bronnert C., Sidorkiewicz M., Gounon P., Dubuisson J., Faure G., Crainic R., Budkowska A. Nonenveloped nucelocapsids of hepatitis C virus in the serum of infected patients. J. Virol. 75:2001;8240-8250.
46. Matsuura Y., Harada S., Suzuki R., Watanabe Y., Inoue Y., Saito I., Miyamura T. Expression of processed envelope protein of hepatitis C virus in mammalian and insect cells. J. Virol. 66:1992;1425-1431.
47. Matsuura Y., Suzuki T., Suzuki R., Sato M., Aizaki H., Saito I., Miyamura T. Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells. Virology. 205:1994;141-150.
48. Meola A., Sbardellati A., Bruni Erocole B., Cerretani M., Pezzanera M., Ceccacci A., Vitelli A., Levy S., Nicosia A., Traboni C., McKeating J., Scarselli E. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection. J. Virol. 74:2000;5933-5938.
49. Meyer K., Basu A., Ray R. Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells. Virology. 276:2000;214-226.
50. Michalak J.-P., Wychowski C., Choukhi A., Meunier J.-C., Ung S., Rice C.M., Dubuisson J. Characterization of truncated forms of hepatitis C virus glycoproteins. J. Gen. Virol. 78:1997;2299-2306.
51. Monazahian M., Bohme I., Bonk S., Koch A., Scholz C., Grethe S., Thomssen R. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J. Med. Virol. 57:1999;223-229.
52. Monazahian M., Kippenberger S., Muller A., Seitz H., Bohme I., Grethe S., Thomssen R. Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus. Med. Microbiol. Immunol. (Berl.). 188:2000;177-184.
53. Nagasaka A., Hige S., Matsushima T., Yoshida J., Sasaki Y., Tsunematsu I., Asaka M. Differential flotation centrifugation study of hepatitis C virus and response to interferon therapy. J. Med. Virol. 52:1997;190-194.
54. Okamoto H., Okada S., Sugiyama S., Tanaka T., Sugai Y., Akahane Y., Machida A., Mishiro S., Yoshizawa H., Miyakawa Y., Mayumi M. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn. J. Exp. Med. 60:1990;215-222.
55. Pearse B.M., Robinson M.S. Clathrin, adaptors, and sorting. Annu. Rev. Cell Biol. 6:1990;151-171.
56. Petracca R., Falugi F., Galli G., Norais N., Rosa D., Campagnoli S., Burgio V., Di Stasio E., Giardina B., Houghton M., Abrignani S., Grandi G. Structure-function analysis of hepatitis C virus envelope-CD81 binding. J. Virol. 74:2000;4824-4830.
57. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., Weiner A.J., Houghton M., Rosa D., Grandi G., Abrignani S. Binding of hepatitis C virus to CD81. Science. 282:1998;938-941.
58. Prince A.M. Challenges for development of hepatitis C virus vaccines. FEMS Microbiol. Rev. 14:1994;273-277.
59. Prince A.M., Huima-Byron T., Parker T.S., Levine D.M. Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins. J. Viral Hepat. 3:1996;11-17.
60. Ralston R., Thudium K., Berger K., Kuo C., Gervase B., Hall J., Selby M., Kuo G., Houghton M., Choo Q.-L. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J. Virol. 67:1993;6753-6761.
61. Reed K.E., Rice C.M. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol. 242:2000;55-84.
62. Rice C.M. Is CD81 the key to hepatitis C virus entry? Hepatology. 29:1999;990-992.
63. Roth M.G., Doyle C., Sambrook J., Gething M.J. Heterologous transmembrane and cytoplasmic domains direct functional chimeric influenza virus hemagglutinins into the endocytotic pathway. J. Cell Biol. 102:1986;1271-1283.
64. Seipp S., Mueller H.M., Pfaff E., Stremmel W., Theilmann L., Goeser T. Establishment of persistent hepatitis C virus infection and replication in vitro. J. Gen. Virol. 78:1997;2467-2476.
65. Selby M.J., Glazer E., Masiarz F., Houghton M. Complex processing and protein:protein interactions in the E2:NS2 region of HCV. Virology. 204:1994;114-122.
66. Takamizawa A., Mori C., Manabe S., Murakami S., Fujita J., Onishi E., Andoh T., Yoshida I., Okayama H. The structure and organization of the Hepatitis C virus genome isolated from human carriers. J. Virol. 65:1991;1105-1113.
67. Takikawa S., Ishii K., Aizaki H., Suzuki T., Asakura H., Matsuura Y., Miyamura T. Cell fusion activity of hepatitis C virus envelope proteins. J. Virol. 74:2000;5066-5074.
68. Thomssen R., Bonk S., Propfe C., Heermann K.H., Kochel H.G., Uy A. Association of hepatitis C virus in human sera with beta-lipoprotein. Med. Microbiol. Immunol. (Berl.). 181:1992;293-330.
69. Thomssen R., Bonk S., Thiele A. Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Med. Microbiol. Immunol. (Berl.). 182:1993;329-334.
70. Trowbridge I.S. Endocytosis and signals for internalization. Curr. Opin. Cell Biol. 3:1991;634-641.
71. van Driel I.R., Brown M.S., Goldstein J.L. Stoichiometric binding of low density lipoprotein (LDL) and monoclonal antibodies to LDL receptors in a solid phase assay. J. Biol. Chem. 264:1989;9533-9538.
72. Watson J.P., Bevitt D.J., Spickett G.P., Toms G.L., Bassendine M.F. Hepatitis C virus density heterogeneity and viral titre in acute and chronic infection: a comparison of immunodeficient and immunocompetent patients. J. Heptatol. 25:1996;599-607.
73. Weiner A.J., Brauer M.J., Rosenblatt J., Richman K.H., Tung J., Crawford K., Binino F., Saracco G., Choo Q.-L., Houghton M., Han J.H. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology. 180:1991;842-848.
74. Wünschmann S., Medh J.D., Klinzmann D., Schmidt W.N., Stapleton J.T. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J. Virol. 74:2000;10055-10062.